Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the β-amyloid precursor protein

Molecular Brain Research

Volumn 26, Issue 1-2, 1994, Pages 207-217

  Sopher, Bryce L ^a   Fukuchi, Ken ichiro ^a   Smith, Annette C ^a   Leppig, Kathy A ^a   Furlong, Clement E ^a   Martin, George M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Cytotoxicity; Neuroblastoma; SK N MC; Tetracycline responsive promoter

Indexed keywords

AMYLOID BETA PROTEIN; BUCLADESINE; COMPLEMENTARY DNA; TETRACYCLINE;

ALZHEIMER DISEASE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BRAIN; BUCLADESINE; CELL LINE; CELL SURVIVAL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; NEUROBLASTOMA; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; RESTRICTION MAPPING; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TETRACYCLINE; TRANSFECTION; TUMOR CELLS, CULTURED;

BOVINAE;

EID: 0027971254     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(94)90092-2     Document Type: Article

References (42)

1. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture
2. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones
3. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor
4. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene
5. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production
6. Cleavage of amyloid beta peptide during constitutive processing of its precursor
7. Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity
8. Expression of a carboxyterminal region of the beta-amyloid precursor protein in a heterogeneous culture of neuroblastoma cells: evidence for altered processing and selective neurotoxicity
9. Selective neurotoxicity of COOH-terminal fragments of the beta-amyloid precursor protein
10. Neurotoxicity of beta-amyloid
11. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
12. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives
13. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
14. Amyloid beta-peptide is produced by cultured cells during normal metabolism
15. Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments
16. β-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms
17. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
18. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin
19. Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line
20. Expression of c-src in cultured human neuroblastoma and small-cell lung carcinoma cell lines correlates with neurocrine differentiation
21. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth
22. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays
23. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid
24. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease
25. Mis-sense mutation Val → He in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease
26. Identification of the Alzheimer beta/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells
27. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons
28. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
29. Chromosome 14 and late-onset familial Alzheimer disease (FAD)
30. Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines
31. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids
32. Production of the Alzheimer amyloid beta protein by normal proteolytic processing
33. Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing
34. Studies on succinate-tetrazolium reductase systems III. Points of coupling of four different tetrazolium salts
35. Identification of a stable fragment of the Alzheimer amyloid precursor containing the beta-protein in brain microvessels
36. Amyloid precursor protein gene mutation in early-onset Alzheimer's disease
37. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
38. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease
39. Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor
40. The 717Val → Ile substitution in amyloid precursor protein is associated with familial Alzheimer's disease regardless of ethnic groups